L
LisaAlissa
Joined:
May 2007
Posts:
1,077
Latest activity:
Aug 14, 2021
Log in to post a reply
Aug 3, 2016 06:28PM
LisaAlissa
wrote:
Yes. One of the coverages will be primary (first payor) and the other secondary (second payor). Which is which depends on a lot of different things. Generally Medicare doesn't pick up all costs, and you'll want another policy to deal with the balance.
You may want to discuss with your HR department (if there is one...). You also want to talk with someone who is familiar with the rules in your state for insurance policies. You might want to talk with the social worker/cancer navigator/financial counselor where your wife gets her treatment. You might also want to talk with your state insurance department for referrals to the type of person who can provide that sort of advice to you in your state.
BTW, some employers self-fund their health insurance. Notwithstanding privacy rules, it can become very obvious who is the source of high-dollar claims under a self-funded health insurance plan, if your company is a small to medium size entity.
HTH,
LisaAlissa
E
edwards750
Joined:
Feb 2011
Posts:
3,714
Latest activity:
Jun 8, 2022
Log in to post a reply
Aug 4, 2016 05:45PM
edwards750
wrote:
You can because I do. My primary is BC/BS through my husband's job and my secondary is Medicare.
Diane
P
pajim
Joined:
May 2008
Posts:
2,784
Latest activity:
Apr 20, 2020
Log in to post a reply
Aug 7, 2016 03:52PM
pajim
wrote:
Yes. My husband is on my insurance and on medicare. When he turned 65 the insurance company required him to sign up for Medicare.
He gets all the benefits of my company's insurance. I have no idea who pays for what, but I imagine Medicare pays for some.
You need to talk with your HR department -- particularly to someone you trust there -- and read all the paperwork very carefully.
Dx
4/20/2008, IDC, Right, 4cm, Stage IIIA, Grade 2, 1/15 nodes, ER+/PR+, HER2-
Dx
2/1/2013, IDC, Stage IV, metastasized to bone, mets, ER+/PR+, HER2-
Hormonal Therapy
2/27/2013 Femara (letrozole)
Hormonal Therapy
4/22/2013 Faslodex (fulvestrant)
Targeted Therapy
2/25/2016 Ibrance (palbociclib)
Chemotherapy
6/19/2017 Xeloda (capecitabine)
Targeted Therapy
8/15/2018 Verzenio
Chemotherapy
1/2/2019 Halaven (eribulin)
Chemotherapy
12/30/2019 CMF